Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Val Gebski

Showing results (111-120 of 248) with videos related to

Pageof 25
Sort By:
Journal of Medical Imaging and Radiation Oncology|September 7, 2018
Long-term outcomes in 1121 Australian prostate cancer patients treated with definitive radiotherapyJeremiah F de Leon, Andrew Kneebone, Val Gebski, et al.
Australasian Radiology|June 13, 2002
Parotid lymph-node metastases from cutaneous squamous-cell carcinomas: treatment outcome and prognostic factors following surgery and adjuvant radiotherapyMargaret S-T Chua, Michael J Veness, Gary Morgan, et al.
JAMA|November 7, 2012
Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trialDavid Sullivan, Anders G Olsson, Rob Scott, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2025
Erratum to 'Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma' [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644]Andreas Obermair, Val Gebski, Jeffrey Goh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 15, 2025
Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinomaAndreas Obermair, Val Gebski, Jeffrey Goh, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|July 24, 2023
Feasibility and safety of a surgical training program in total laparoscopic hysterectomy: Results of a pilot trialAndreas Obermair, George B Hanna, Val Gebski, et al.
Neurourology and Urodynamics|September 29, 2020
Effect of antibiotics on urine leakage in women with refractory detrusor overactivity: A phase IIb randomized trialZhuoran Chen, Kate H Moore, Kylie J Mansfield, et al.
Practical Radiation Oncology|November 1, 2020
Patient-Specific Heart Constraint: A Tool for Optimization and Evaluation of Mean Heart Dose in Breast Cancer PatientsRachel Ward, Katrina West, Drew Latty, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 5, 2024
Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trialFlorencia Virili, Andreas Obermair, Saira Sanjida, et al.
ANZ Journal of Surgery|March 22, 2005
Participation in the RACS sentinel node biopsy versus axillary clearance trialNeil R Wetzig, P Grantley Gill, Owen Ung, et al.
Pageof 25

Showing results (111-120 of 248) with videos related to

Sort By:
Pageof 25
Journal of Medical Imaging and Radiation Oncology|September 7, 2018
Long-term outcomes in 1121 Australian prostate cancer patients treated with definitive radiotherapyJeremiah F de Leon, Andrew Kneebone, Val Gebski, et al.
Australasian Radiology|June 13, 2002
Parotid lymph-node metastases from cutaneous squamous-cell carcinomas: treatment outcome and prognostic factors following surgery and adjuvant radiotherapyMargaret S-T Chua, Michael J Veness, Gary Morgan, et al.
JAMA|November 7, 2012
Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trialDavid Sullivan, Anders G Olsson, Rob Scott, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2025
Erratum to 'Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma' [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644]Andreas Obermair, Val Gebski, Jeffrey Goh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 15, 2025
Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinomaAndreas Obermair, Val Gebski, Jeffrey Goh, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|July 24, 2023
Feasibility and safety of a surgical training program in total laparoscopic hysterectomy: Results of a pilot trialAndreas Obermair, George B Hanna, Val Gebski, et al.
Neurourology and Urodynamics|September 29, 2020
Effect of antibiotics on urine leakage in women with refractory detrusor overactivity: A phase IIb randomized trialZhuoran Chen, Kate H Moore, Kylie J Mansfield, et al.
Practical Radiation Oncology|November 1, 2020
Patient-Specific Heart Constraint: A Tool for Optimization and Evaluation of Mean Heart Dose in Breast Cancer PatientsRachel Ward, Katrina West, Drew Latty, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 5, 2024
Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trialFlorencia Virili, Andreas Obermair, Saira Sanjida, et al.
ANZ Journal of Surgery|March 22, 2005
Participation in the RACS sentinel node biopsy versus axillary clearance trialNeil R Wetzig, P Grantley Gill, Owen Ung, et al.
Pageof 25